BlackRock, Inc.

Holdings History for Lineage Cell Therapeutics, Inc. - Common shares (LCTX)

Symbol: LCTX on NYSE
Investment type: Equity / Common shares
Latest Disclosed Shares Owned: 2,234,545 shares
Security Ownership %: 1%

Shares, Excluding Options vs Price

Value, Excluding Options

BlackRock, Inc. ownership in Lineage Cell Therapeutics, Inc. Common shares (LCTX)

17 Jul 2025 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,234,545 shares of Lineage Cell Therapeutics, Inc. Common shares (LCTX). This represents 1% ownership of the company. In their previous filing dated 24 Apr 2025, BlackRock, Inc. had reported owning 11,453,305 shares, indicating a decrease of +80%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BlackRock, Inc.	1%	-80%	$2,027,626	2,234,545	-9,218,760	-80%	$0.91	13G/A	30 Jun 2025	17 Jul 2025, 19:54
BlackRock, Inc.	5%	+8%	$5,726,652	11,453,305	+1,358,628	+13%	$0.50	13G	31 Mar 2025	24 Apr 2025, 08:48
BlackRock, Inc.	4.6%		$5,047,338	10,094,677			$0.50	13G/A	31 Dec 2024	05 Feb 2025, 17:28

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$6,402,969	3,834,113	+1,603,357	+72%	$1.67	Q4 2025
30 Sep 2025	0%	-0%	$3,769,978	2,230,756	-29,992	-1.3%	$1.69	Q3 2025
30 Jun 2025	0%	-0%	$2,051,403	2,260,748	-9,192,557	-80%	$0.91	Q2 2025
31 Mar 2025	0%	+0%	$5,172,314	11,453,305	+1,358,628	+13%	$0.45	Q1 2025
31 Dec 2024	0%	+0%	$5,072,576	10,094,677	+174,877	+1.8%	$0.50	Q4 2024
30 Sep 2024	0%	0%	$8,980,394	9,919,800	0		$0.91	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.